|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-4-18
|
|
pubmed:abstractText |
To assess the effect of highly active antiretroviral therapy (HAART) on surrogate markers of lymphocyte apoptosis in HIV 1-infected individuals.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ADP-ribosyl Cyclase,
http://linkedlifedata.com/resource/pubmed/chemical/Annexin A5,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD38,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/CD38 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
111-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12702131-ADP-ribosyl Cyclase,
pubmed-meshheading:12702131-Adult,
pubmed-meshheading:12702131-Annexin A5,
pubmed-meshheading:12702131-Antibodies, Monoclonal,
pubmed-meshheading:12702131-Antigens, CD,
pubmed-meshheading:12702131-Antigens, CD38,
pubmed-meshheading:12702131-Antigens, CD95,
pubmed-meshheading:12702131-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:12702131-Apoptosis,
pubmed-meshheading:12702131-B-Lymphocytes,
pubmed-meshheading:12702131-Biological Markers,
pubmed-meshheading:12702131-CD4 Lymphocyte Count,
pubmed-meshheading:12702131-CD4-Positive T-Lymphocytes,
pubmed-meshheading:12702131-CD8-Positive T-Lymphocytes,
pubmed-meshheading:12702131-Female,
pubmed-meshheading:12702131-Flow Cytometry,
pubmed-meshheading:12702131-HIV Infections,
pubmed-meshheading:12702131-HIV-1,
pubmed-meshheading:12702131-HLA-DR Antigens,
pubmed-meshheading:12702131-Humans,
pubmed-meshheading:12702131-Killer Cells, Natural,
pubmed-meshheading:12702131-Lymphocyte Activation,
pubmed-meshheading:12702131-Lymphocytes,
pubmed-meshheading:12702131-Male,
pubmed-meshheading:12702131-Membrane Glycoproteins,
pubmed-meshheading:12702131-Membrane Proteins,
pubmed-meshheading:12702131-Middle Aged,
pubmed-meshheading:12702131-Statistics, Nonparametric,
pubmed-meshheading:12702131-Viral Load
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University of Bonn, Germany. j-c.wasmuth@uni-bonn.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
